Published in J Med Virol on January 01, 2003
Health care costs associated with hepatitis C: a longitudinal cohort study. Can J Gastroenterol (2010) 1.07
A New Twist to a Chronic HCV Infection: Occult Hepatitis C. Gastroenterol Res Pract (2015) 0.77
Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med (2007) 13.43
A SNP in the ABCC11 gene is the determinant of human earwax type. Nat Genet (2006) 2.29
Determinants of thrombin generation, fibrinolytic activity, and endothelial dysfunction in patients on dual antiplatelet therapy: involvement of factors other than platelet aggregability in Virchow's triad. Eur Heart J (2008) 2.04
Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus. Proc Natl Acad Sci U S A (2002) 1.90
Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing. Malar J (2008) 1.85
Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int J Cancer (2006) 1.82
Diversity of the sarco/endoplasmic reticulum Ca(2+)-ATPase orthologue of Plasmodium falciparum (PfATP6). Infect Genet Evol (2008) 1.80
Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. Am J Trop Med Hyg (2003) 1.78
Plasmodium falciparum accompanied the human expansion out of Africa. Curr Biol (2010) 1.65
Identification of mechanically induced genes in human monocytic cells by DNA microarrays. J Hypertens (2002) 1.61
Chronic hepatitis B in patients coinfected with human immunodeficiency virus in Japan: a retrospective multicenter analysis. J Infect Chemother (2012) 1.47
Anemia and malaria at different altitudes in the western highlands of Kenya. Acta Trop (2004) 1.44
Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J Hepatol (2006) 1.40
Expansion of wild type allele rather than back mutation in pfcrt explains the recent recovery of chloroquine sensitivity of Plasmodium falciparum in Malawi. Mol Biochem Parasitol (2004) 1.30
Improved detection of lung nodules on chest radiographs using a commercial computer-aided diagnosis system. AJR Am J Roentgenol (2004) 1.30
The involvement of neutrophils in the resistance to Leishmania major infection in susceptible but not in resistant mice. Parasitol Int (2005) 1.28
Plasmodium falciparum multidrug resistance protein 1 and artemisinin-based combination therapy in Africa. J Infect Dis (2009) 1.26
Plasmacytoid urothelial carcinoma of the bladder. Int J Urol (2006) 1.25
Long-term histologic and virologic outcomes of acute self-limited hepatitis B. Hepatology (2003) 1.24
Pulmonary mucinous cystadenocarcinoma: an extremely rare tumor presenting as a cystic lesion of the lung. Gen Thorac Cardiovasc Surg (2007) 1.21
Surgically removed thoracolithiasis: report of two cases. Ann Thorac Cardiovasc Surg (2006) 1.20
Changing patterns of forest malaria among the mobile adult male population in Chumkiri District, Cambodia. Acta Trop (2008) 1.20
Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy. J Hepatol (2010) 1.18
Independent evolution of pyrimethamine resistance in Plasmodium falciparum isolates in Melanesia. Antimicrob Agents Chemother (2007) 1.17
Population pharmacokinetics of amodiaquine and desethylamodiaquine in pediatric patients with uncomplicated falciparum malaria. J Pharmacokinet Pharmacodyn (2007) 1.16
Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann Intern Med (2008) 1.16
Malaria transmission pattern resilience to climatic variability is mediated by insecticide-treated nets. Malar J (2008) 1.14
A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis. J Gastroenterol (2010) 1.10
Identification of IEX-1 as a biomechanically controlled nuclear factor-kappaB target gene that inhibits cardiomyocyte hypertrophy. Circ Res (2002) 1.10
Gene expression profiling of human atrial myocardium with atrial fibrillation by DNA microarray analysis. Int J Cardiol (2005) 1.10
The complete nucleotide sequence of the hornwort (Anthoceros formosae) chloroplast genome: insight into the earliest land plants. Nucleic Acids Res (2003) 1.09
Electrophysiological mechanism of enhanced susceptibility of hypertrophied heart to acquired torsade de pointes arrhythmias: tridimensional mapping of activation and recovery patterns. Circulation (2002) 1.08
Role of pfmdr1 mutations on chloroquine resistance in Plasmodium falciparum isolates with pfcrt K76T from Papua New Guinea. Acta Trop (2006) 1.07
Novel mutations in K13 propeller gene of artemisinin-resistant Plasmodium falciparum. Emerg Infect Dis (2015) 1.07
Repair of infarcted myocardium mediated by transplanted bone marrow-derived CD34+ stem cells in a nonhuman primate model. Stem Cells (2005) 1.06
Indigenous evolution of Plasmodium falciparum pyrimethamine resistance multiple times in Africa. J Antimicrob Chemother (2008) 1.03
Dose-finding trial of tolvaptan in liver cirrhosis patients with hepatic edema: A randomized, double-blind, placebo-controlled trial. Hepatol Res (2013) 1.02
T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection. Clin Infect Dis (2005) 1.02
Spontaneous mutations in the Plasmodium falciparum sarcoplasmic/ endoplasmic reticulum Ca2+-ATPase (PfATP6) gene among geographically widespread parasite populations unexposed to artemisinin-based combination therapies. Antimicrob Agents Chemother (2010) 1.01
Computer-aided nodule detection on digital chest radiography: validation test on consecutive T1 cases of resectable lung cancer. J Digit Imaging (2006) 1.01
QT PRODACT: in vivo QT assay in the conscious dog for assessing the potential for QT interval prolongation by human pharmaceuticals. J Pharmacol Sci (2005) 1.00
Circulating endothelial progenitor cells in congestive heart failure. Int J Cardiol (2006) 0.99
When they don't bite, we smell money: understanding malaria bednet misuse. Parasitology (2013) 0.99
Adeno-associated virus vector-mediated systemic interleukin-10 expression ameliorates hypertensive organ damage in Dahl salt-sensitive rats. J Gene Med (2008) 0.99
The Plasmodium apicoplast genome: conserved structure and close relationship of P. ovale to rodent malaria parasites. Mol Biol Evol (2012) 0.99
PfMDR1: mechanisms of transport modulation by functional polymorphisms. PLoS One (2011) 0.98
Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer. Oncol Rep (2005) 0.97
Stereotactic single high dose irradiation of lung tumors under respiratory gating. Radiother Oncol (2002) 0.97
Random, top-down, or bottom-up coexistence of parasites: malaria population dynamics in multi-parasitic settings. Ecology (2009) 0.96
The origins of African Plasmodium vivax; insights from mitochondrial genome sequencing. PLoS One (2011) 0.96
IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease. Am J Gastroenterol (2008) 0.95
HMG-CoA reductase inhibitors reduce interleukin-6 synthesis in human vascular smooth muscle cells. Cardiovasc Drugs Ther (2002) 0.95
Rapid selection of dhfr mutant allele in Plasmodium falciparum isolates after the introduction of sulfadoxine/pyrimethamine in combination with 4-aminoquinolines in Papua New Guinea. Infect Genet Evol (2006) 0.95
Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway. Cancer Res (2003) 0.95
Predictive factors for postoperative acute exacerbation of interstitial pneumonia combined with lung cancer. Gen Thorac Cardiovasc Surg (2010) 0.94
Integration of temporal subtraction and nodule detection system for digital chest radiographs into picture archiving and communication system (PACS): four-year experience. J Digit Imaging (2007) 0.94
Behavioral risk factors for obesity during health transition in Vanuatu, South Pacific. Obesity (Silver Spring) (2013) 0.94
Clues to evolution of the SERA multigene family in 18 Plasmodium species. PLoS One (2011) 0.93
THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritis. Arthritis Res Ther (2006) 0.92
Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection. J Gastroenterol (2012) 0.92
Synergistic antitumor effects of celecoxib with 5-fluorouracil depend on IFN-gamma. Int J Cancer (2007) 0.92
Anti-CYP2D6 antibodies detected by quantitative radioligand assay and relation to antibodies to liver-specific arginase in patients with autoimmune hepatitis. Clin Chim Acta (2002) 0.92
A new electrocautery pleural biopsy technique using an insulated-tip diathermic knife during semirigid pleuroscopy. Surg Endosc (2009) 0.91
Molecular insights into beta-galactoside alpha2,6-sialyltransferase secretion in vivo. Glycobiology (2009) 0.91
Juvenile hepatocellular carcinoma with congestive liver cirrhosis. J Gastroenterol (2005) 0.91
Large-scale survey for novel genotypes of Plasmodium falciparum chloroquine-resistance gene pfcrt. Malar J (2012) 0.91
Stabilization of a supersaturated solution of mefenamic acid from a solid dispersion with EUDRAGIT(®) EPO. Pharm Res (2012) 0.91
Safety pharmacology in 2010 and beyond: survey of significant events of the past 10 years and a roadmap to the immediate-, intermediate- and long-term future in recognition of the tenth anniversary of the Safety Pharmacology Society. J Pharmacol Toxicol Methods (2011) 0.91
Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivax. Vaccine (2011) 0.91
QT PRODACT: comparison of non-clinical studies for drug-induced delay in ventricular repolarization and their role in safety evaluation in humans. J Pharmacol Sci (2005) 0.90
Long-term clinical and virological outcomes of chronic hepatitis C after successful interferon therapy. J Med Virol (2004) 0.90
The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan. J Gastroenterol (2011) 0.89
Assessment of liver fibrosis with real-time tissue elastography in chronic viral hepatitis. Oncology (2013) 0.89
Geographic differentiation of polymorphism in the Plasmodium falciparum malaria vaccine candidate gene SERA5. Vaccine (2012) 0.88
Spleen rates in children: an old and new surveillance tool for malaria elimination initiatives in island settings. Trans R Soc Trop Med Hyg (2011) 0.88
[In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,919 clinical isolates obtained from 72 centers in 2007]. Jpn J Antibiot (2009) 0.88
Physicochemical characterization and structural evaluation of a specific 2:1 cocrystal of naproxen-nicotinamide. J Pharm Sci (2012) 0.88
DNA microarray analysis of in vivo progression mechanism of heart failure. Biochem Biophys Res Commun (2003) 0.88
The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation. Mol Cancer Res (2010) 0.88
Non-invasive evaluation of hepatic fibrosis for type C chronic hepatitis. Intervirology (2010) 0.88
Patterns of childhood and adolescent overweight and obesity during health transition in Vanuatu. Public Health Nutr (2011) 0.87
QT PRODACT: in vivo QT assay in anesthetized dog for detecting the potential for QT interval prolongation by human pharmaceuticals. J Pharmacol Sci (2005) 0.87
QT PRODACT: in vivo QT assay with a conscious monkey for assessment of the potential for drug-induced QT interval prolongation. J Pharmacol Sci (2005) 0.87
Behavioral changes associated with economic development in the South Pacific: health transition in Vanuatu. Am J Hum Biol (2011) 0.87
Significance of liver negative-strand HCV RNA quantitation in chronic hepatitis C. J Hepatol (2005) 0.87
Functional molecular imaging of ILK-mediated Akt/PKB signaling cascades and the associated role of beta-parvin. J Cell Sci (2010) 0.86